- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Do | Pharming Group N.V.: Pharming Group announces the placement of €100 million convertible bonds due 2029 | 203 | NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW.
Leiden... ► Artikel lesen | ||
| Do | Fluence Releases Annual Sustainability Report | 124 | Report outlines increased sustainability disclosures, including Fluence's first Task Force on Climate-Related Financial Disclosures(the "Report") providing updates on the company's sustainability strategy... ► Artikel lesen | ||
| Do | Modelo Spiked Aguas Frescas Teams Up With Actress Francia Raisa and Community Changemaker Juixxe to Honor the Street Vendor Community | 159 | As Modelo Spiked Aguas Frescas expands to multiple markets, it celebrates street vendors who inspired the beverage by rewarding an aguas frescas street vendor with a custom-made cart and financial support... ► Artikel lesen | ||
| Do | LogicMark, Inc. Reports Fourth Quarter and Full Year 2023 Results | 52 | LOUISVILLE, Ky., April 18, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc.?(Nasdaq: LGMK), a provider of personal emergency response systems (PERS), health communications devices, and technology for the... ► Artikel lesen | ||
| Do | Truxton Trust Company: Truxton Corporation Reports First Quarter 2024 Results | 41 | NASHVILLE, Tenn., April 18, 2024 (GLOBE NEWSWIRE) -- Truxton Corporation, the parent company for Truxton Trust Company ("Truxton" or "the Bank") and subsidiaries, announced its operating results for... ► Artikel lesen | ||
| Do | Oncternal Therapeutics: Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer | 39 | SAN DIEGO, April 18, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today... ► Artikel lesen | ||
| Do | Renovaro Biosciences Inc.: Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screenin | 122 | LOS ANGELES and AMSTERDAM, April 18, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (Nasdaq: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, announces the distinguished... ► Artikel lesen | ||
| Do | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Results | 135 | NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | ||
| Do | Alm. Brand A/S - Result of annual general meeting held on 18 April 2024 | 35 | The annual general meeting of Alm. Brand A/S held today was conducted in accordance with the agenda and the complete proposals submitted by the Board of Directors. The annual report for 2023 was... ► Artikel lesen | ||
| Do | Ohmyhome Ltd.: Ohmyhome Reports 2023 Full-Year Results | 62 | Ohmyhome achieves S$5.0 million 2023, launches HomerAI and completes acquisition of its Property Management business, and is poised for 3X Growth in 2024 and a positive Adjusted EBITDA in Q4 2024... ► Artikel lesen | ||
| Do | Imunon, Inc.: IMUNON's IND Application Cleared to Begin Human Testing of IMNN-101 | 1.179 | Company expects enrollment in Phase 1 proof-of-concept study of DNA-based vaccine technology to begin in the second quarter LAWRENCEVILLE, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:... ► Artikel lesen | ||
| Do | Mullen Automotive, Inc.: Mullen Achieves Manufacturing Milestone with 500th Commercial Vehicle Produced | 91 | BREA, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- via IBN -- Mullen Automotive Inc. (NASDAQ: MULN), an emerging electric vehicle ("EV") manufacturer, today announces a manufacturing milestone achieved... ► Artikel lesen | ||
| Do | Data443 Risk Mitigation, Inc.: Data443 Reports 112% Revenue Increase, 57% Reduction in Net Loss for Fiscal Year 2023 | 339 | RESEARCH TRIANGLE PARK, N.C., April 18, 2024 (GLOBE NEWSWIRE) -- Data443 Risk Mitigation, Inc. (OTCPK: ATDS) ("Data443" or the "Company"), a data security and privacy software company for "All Things... ► Artikel lesen | ||
| Do | WillScot Mobile Mini Holdings Corp.: WillScot Mobile Mini to Announce First Quarter 2024 Results on May 2, 2024 | 195 | PHOENIX, April 18, 2024 (GLOBE NEWSWIRE) -- WillScot Mobile Mini Holdings Corp. ("WillScot Mobile Mini" or the "Company") (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced... ► Artikel lesen | ||
| Do | Canacol Energy Ltd. Announces New Gas Discovery at Chontaduro 1 | 84 | CALGARY, Alberta, April 18, 2024 (GLOBE NEWSWIRE) -- Canacol Energy Ltd. ("Canacol" or the "Corporation") (TSX:CNE; OTCQX:CNNEF; BVC:CNEC) is pleased to provide the following information concerning... ► Artikel lesen | ||
| Do | Windtree Therapeutics Announces Reverse Stock Split | 73 | WARRINGTON, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NASDAQ: WINT) ("Windtree" or the "Company"), a biotechnology company focused on advancing early and late-stage innovative... ► Artikel lesen | ||
| Do | NevGold Corp.: NevGold Announces Positive Copper Porphyry Potential at the Zeus Copper Project in the Hercules Copper Trend, Idaho | 180 | VANCOUVER, British Columbia, April 18, 2024 (GLOBE NEWSWIRE) -- NevGold Corp. ("NevGold" or the "Company") (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce that it has identified significant
copper... ► Artikel lesen | ||
| Do | DeFi Technologies Inc.: DeFi Technologies Subsidiary Valour Inc. Launches the First Short Spot Bitcoin ETP in the Nordics | 1.269 | Innovative Bitcoin Financial Product: DeFi Technologies, through its subsidiary Valour, has launched the first Short Spot Bitcoin ETP in the Nordics, known as Valour Short Bitcoin (SBTC) SEK (ISIN:... ► Artikel lesen | ||
| Do | Benitec Biopharma Inc.: Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study | 76 | -First efficacy signals demonstrated for a gene therapy under development for Oculopharyngeal Muscular Dystrophy (OPMD) which affects ~15,000 patients worldwide- - BB-301 facilitated improvements... ► Artikel lesen | ||
| Do | TG Therapeutics, Inc.: TG Therapeutics Announces Additional Data Presentations for BRIUMVI (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting | 44 | NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced two additional data presentations from the ULTIMATE I & II Phase 3 trials evaluating BRIUMVI® (ublituximab-xiiy)... ► Artikel lesen | ||
| Do | Smith & Nephew UK Ltd: Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing's role in pressure injury prevention | 151 | Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group... ► Artikel lesen | ||
| Do | Anaqua Transforms Foreign Patent Filing into a Strategic Advantage for Intellectual Property Professionals | 101 | BOSTON, April 18, 2024, the leading provider of innovation and intellectual property (IP) management technology for corporations, law firms and governments, announces advancements in its Foreign Filing... ► Artikel lesen | ||
| Do | Tiziana Life Sciences Ltd.: Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology | 128 | Oral presentation of study shows intranasal foralumab attenuates microglial activation and disease progression in multiple sclerosis (MS) patients with PIRA as measured by changes in PET scansNEW YORK... ► Artikel lesen | ||
| Do | Chemomab Therapeutics: Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis | 34 | -Longitudinal Study of a 200+ Real-World Patient Cohort Further Validates CCL24 as a Novel Target for Systemic Sclerosis (SSc), Showing that It is Associated with Disease Severity Across the Fibrotic... ► Artikel lesen | ||
| Do | Ocular Therapeutix, Inc.: Ocular Therapeutix Announces Positive Topline Phase 1 Data for AXPAXLI in Diabetic Retinopathy | 214 | 46.2% of patients demonstrated a 1- or 2-step improvement in the Diabetic Retinopathy Severity Scale (DRSS) at 40 weeks in the AXPAXLI arm, compared to 0% in the control arm No patients in the AXPAXLI... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
